Home » Newsletters » BioWorld Asia

BioWorld Asia

July 1, 1998

View Archived Issues

Tm Raises C$14M For Programs Using 'Second Genetic Code'

Cerebrus Forms Joint Venture With Wolfson Institute For CNS

EU Climate Continues To Worsen For Biotech

Sugar-Coated Bioweapon Shows Resilience Of Anthrax

Cambridge Antibody Pays US$11M For Polysome Display Firm

EC Supports US$150M For Biotech Projects

Public Urges French Officials To Monitor Transgenic Plants

Peptech Shares Fluctuate With Veterinary Drug Approval

Enzacta Takes Different Approach To Cancer Chemotherapies

Cerep Licenses Gene Profile System From Xenometrix

Israeli PM Backs Participation In European R&D Program

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Pre-disease plasma signature may help redefine lung cancer risk
BioWorld
Researchers have identified a 14-protein blood signature that can predict lung cancer risk as much as five years before diagnosis, and the findings could help...
Europe’s Alzecure, Orionis in $1B+ deals with Lilly, Novartis
BioWorld
Two companies with European ties signed billion-dollar deals with large pharma firms in the last two days to discover and develop molecular glue drugs, as well as...
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...